EyeCare Partners releases Quality and Outcomes Report, highlights optometric successes
The report highlights clinical successes, innovation, research, and patient outcomes.
VBM reform efforts continue with latest bill introduction
The Vision Lab Choice Act of 2025, S 1716 was introduced to the US Senate floor on May 12.
Taking your OCT outside of the posterior pole
Incorporating peripheral OCTs into your practice provides valuable insights that may alter your clinical diagnosis.
HIV drug lamivudine holds potential for patients with DME, researchers find
Researchers hypothesize that lamivudine was effective in the clinical trial against DME because the drug blocks the activity of inflammasomes.
Individualizing optometry care to all patient populations
Bryce St Clair, OD, MPH, authors the June edition of the Cultural Responsiveness Blog, and urges doctors to consider cultural and socioeconomic backgrounds when caring for patients.
EssilorLuxottica slated to acquire Optegra clinics
The ophthalmology platform Optegra operates more than 70 eye hospitals and diagnostic facilities in 5 European markets.
Cohort study evaluates association between POAG and mental health
The study was an outgrowth of the phase 1 and 2 Ocular Hypertension Treatment Study (OHTS).
ZEISS fundus imaging device receives NMPA approval in China
CLARUS 700, the advanced retinal imaging system, captures 133 degrees in a single image and up to 267 degrees with multiple images.
Researchers develop handheld device to improve early detection, treatment of amblyopia
The device was developed by Curators’ Distinguished Teaching Professor Carl Bassi and research collaborators Michael Howe and Wayne Garver of the University of Missouri – St Louis.
Refractive surgery real talk on SMILE, LASIK, PRK, RLE, and ICL
Takeaways from this week in optometry: June 2 - June 6
Catch up on the top stories in optometry during the week of June 2-June 6.
CCS 2025: Clinical pearls and forward thinking are the key to success in myopia management
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
At the 2025 ASCRS meeting, Mitch Shultz, MD, presented compelling new findings from a 12-week clinical trial investigating the impact of lotilaner 0.25% ophthalmic solution on meibomian gland function.
European Commission approves low-dose atropine eye drop Ryjunea, Santen announces
The 0.1 mg/mL atropine eye drop for pediatric myopia is licensed from Sydnexis, Inc.
Atropine vs spectacles: Which move will be more powerful in the game of myopia management?
An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.
CCS 2025: Tackling the complexities of glaucoma management
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Bausch + Lomb launch Blink Nourish Lubricating eye drops and Blink Boost Lubricating eye drops in the US for dry eye
Both preservative-free, contact lens-friendly drops will be available in most national retailers.
iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia
IVMED-85 is a preservative-free, nonatropine daily drop that slows myopia progression by strengthening scleral and corneal collagen crosslinks via LOX activation.
HOYA announces acquisition of Centennial Optical
This strategic investment will allow both companies to better serve the Canadian market.
CCS 2025: Collaborative retinal disease management in the preoperative refractive surgery patient
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Business partners shaking hands at table Image credit: AdobeStock/Kritdanai")
